nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—CYP2C8—Paclitaxel—ovarian cancer	0.0614	0.249	CbGbCtD
Meloxicam—CYP3A4—Topotecan—ovarian cancer	0.0503	0.204	CbGbCtD
Meloxicam—CYP2C9—Paclitaxel—ovarian cancer	0.0428	0.174	CbGbCtD
Meloxicam—CYP3A4—Vinorelbine—ovarian cancer	0.0354	0.144	CbGbCtD
Meloxicam—CYP3A4—Paclitaxel—ovarian cancer	0.0249	0.101	CbGbCtD
Meloxicam—PTGS2—ovarian follicle—ovarian cancer	0.0193	0.137	CbGeAlD
Meloxicam—CYP3A4—Docetaxel—ovarian cancer	0.018	0.0731	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—ovarian cancer	0.0134	0.0545	CbGbCtD
Meloxicam—PTGS1—oviduct—ovarian cancer	0.00888	0.063	CbGeAlD
Meloxicam—PGD—myometrium—ovarian cancer	0.00679	0.0481	CbGeAlD
Meloxicam—PGD—uterine cervix—ovarian cancer	0.00528	0.0375	CbGeAlD
Meloxicam—PGD—decidua—ovarian cancer	0.00503	0.0357	CbGeAlD
Meloxicam—PGD—endometrium—ovarian cancer	0.00478	0.0339	CbGeAlD
Meloxicam—PGD—gonad—ovarian cancer	0.00443	0.0314	CbGeAlD
Meloxicam—PGD—uterus—ovarian cancer	0.0044	0.0312	CbGeAlD
Meloxicam—PGD—female reproductive system—ovarian cancer	0.00396	0.0281	CbGeAlD
Meloxicam—PGD—bone marrow—ovarian cancer	0.00374	0.0265	CbGeAlD
Meloxicam—PGD—female gonad—ovarian cancer	0.0036	0.0255	CbGeAlD
Meloxicam—PGD—vagina—ovarian cancer	0.00358	0.0254	CbGeAlD
Meloxicam—PGD—testis—ovarian cancer	0.00319	0.0227	CbGeAlD
Meloxicam—ABCC4—uterus—ovarian cancer	0.00313	0.0222	CbGeAlD
Meloxicam—ABCC4—female reproductive system—ovarian cancer	0.00281	0.02	CbGeAlD
Meloxicam—PTGS2—myometrium—ovarian cancer	0.00272	0.0193	CbGeAlD
Meloxicam—ABCC4—bone marrow—ovarian cancer	0.00266	0.0189	CbGeAlD
Meloxicam—PTGS2—embryo—ovarian cancer	0.00261	0.0185	CbGeAlD
Meloxicam—ABCC4—female gonad—ovarian cancer	0.00256	0.0182	CbGeAlD
Meloxicam—CYP2C8—endometrium—ovarian cancer	0.00247	0.0175	CbGeAlD
Meloxicam—PGD—lymph node—ovarian cancer	0.00231	0.0164	CbGeAlD
Meloxicam—ABCC4—testis—ovarian cancer	0.00227	0.0161	CbGeAlD
Meloxicam—PTGS1—epithelium—ovarian cancer	0.00223	0.0158	CbGeAlD
Meloxicam—PTGS1—uterine cervix—ovarian cancer	0.00221	0.0157	CbGeAlD
Meloxicam—PTGS2—epithelium—ovarian cancer	0.00213	0.0151	CbGeAlD
Meloxicam—PTGS2—uterine cervix—ovarian cancer	0.00211	0.015	CbGeAlD
Meloxicam—CYP2C8—female reproductive system—ovarian cancer	0.00204	0.0145	CbGeAlD
Meloxicam—PTGS1—endometrium—ovarian cancer	0.002	0.0142	CbGeAlD
Meloxicam—PTGS2—endometrium—ovarian cancer	0.00191	0.0136	CbGeAlD
Meloxicam—CYP2C8—vagina—ovarian cancer	0.00185	0.0131	CbGeAlD
Meloxicam—PTGS1—uterus—ovarian cancer	0.00184	0.0131	CbGeAlD
Meloxicam—CYP2C9—female reproductive system—ovarian cancer	0.00182	0.0129	CbGeAlD
Meloxicam—PTGS2—uterus—ovarian cancer	0.00176	0.0125	CbGeAlD
Meloxicam—PTGS1—female reproductive system—ovarian cancer	0.00166	0.0118	CbGeAlD
Meloxicam—CYP2C8—testis—ovarian cancer	0.00165	0.0117	CbGeAlD
Meloxicam—ABCC4—lymph node—ovarian cancer	0.00165	0.0117	CbGeAlD
Meloxicam—PTGS2—female reproductive system—ovarian cancer	0.00158	0.0112	CbGeAlD
Meloxicam—PTGS1—female gonad—ovarian cancer	0.00151	0.0107	CbGeAlD
Meloxicam—PTGS1—vagina—ovarian cancer	0.0015	0.0106	CbGeAlD
Meloxicam—PTGS2—bone marrow—ovarian cancer	0.0015	0.0106	CbGeAlD
Meloxicam—PTGS2—female gonad—ovarian cancer	0.00144	0.0102	CbGeAlD
Meloxicam—PTGS2—vagina—ovarian cancer	0.00143	0.0102	CbGeAlD
Meloxicam—CYP3A4—female reproductive system—ovarian cancer	0.00138	0.00982	CbGeAlD
Meloxicam—PTGS1—testis—ovarian cancer	0.00134	0.00949	CbGeAlD
Meloxicam—PTGS1—lymph node—ovarian cancer	0.000969	0.00688	CbGeAlD
Meloxicam—PTGS2—lymph node—ovarian cancer	0.000927	0.00657	CbGeAlD
Meloxicam—Conjunctivitis—Epirubicin—ovarian cancer	0.000378	0.000676	CcSEcCtD
Meloxicam—Urinary tract infection—Epirubicin—ovarian cancer	0.000378	0.000676	CcSEcCtD
Meloxicam—Decreased appetite—Paclitaxel—ovarian cancer	0.000378	0.000674	CcSEcCtD
Meloxicam—Dry mouth—Docetaxel—ovarian cancer	0.000376	0.00067	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000376	0.00067	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000375	0.000669	CcSEcCtD
Meloxicam—Fatigue—Paclitaxel—ovarian cancer	0.000375	0.000668	CcSEcCtD
Meloxicam—Sweating—Epirubicin—ovarian cancer	0.000373	0.000666	CcSEcCtD
Meloxicam—Pollakiuria—Doxorubicin—ovarian cancer	0.000373	0.000666	CcSEcCtD
Meloxicam—Constipation—Paclitaxel—ovarian cancer	0.000371	0.000663	CcSEcCtD
Meloxicam—Pain—Paclitaxel—ovarian cancer	0.000371	0.000663	CcSEcCtD
Meloxicam—Haematuria—Epirubicin—ovarian cancer	0.000371	0.000663	CcSEcCtD
Meloxicam—Confusional state—Docetaxel—ovarian cancer	0.000371	0.000663	CcSEcCtD
Meloxicam—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000369	0.000658	CcSEcCtD
Meloxicam—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000368	0.000657	CcSEcCtD
Meloxicam—Oedema—Docetaxel—ovarian cancer	0.000368	0.000657	CcSEcCtD
Meloxicam—Anaphylactic shock—Docetaxel—ovarian cancer	0.000368	0.000657	CcSEcCtD
Meloxicam—Weight increased—Doxorubicin—ovarian cancer	0.000368	0.000656	CcSEcCtD
Meloxicam—Infection—Docetaxel—ovarian cancer	0.000366	0.000653	CcSEcCtD
Meloxicam—Weight decreased—Doxorubicin—ovarian cancer	0.000366	0.000653	CcSEcCtD
Meloxicam—Sinusitis—Epirubicin—ovarian cancer	0.000365	0.000652	CcSEcCtD
Meloxicam—Agranulocytosis—Epirubicin—ovarian cancer	0.000363	0.000649	CcSEcCtD
Meloxicam—Shock—Docetaxel—ovarian cancer	0.000362	0.000647	CcSEcCtD
Meloxicam—Nervous system disorder—Docetaxel—ovarian cancer	0.000361	0.000644	CcSEcCtD
Meloxicam—Thrombocytopenia—Docetaxel—ovarian cancer	0.00036	0.000643	CcSEcCtD
Meloxicam—Drowsiness—Doxorubicin—ovarian cancer	0.00036	0.000643	CcSEcCtD
Meloxicam—Infestation NOS—Doxorubicin—ovarian cancer	0.00036	0.000643	CcSEcCtD
Meloxicam—Infestation—Doxorubicin—ovarian cancer	0.00036	0.000643	CcSEcCtD
Meloxicam—Tachycardia—Docetaxel—ovarian cancer	0.000359	0.000641	CcSEcCtD
Meloxicam—Feeling abnormal—Paclitaxel—ovarian cancer	0.000358	0.000639	CcSEcCtD
Meloxicam—Skin disorder—Docetaxel—ovarian cancer	0.000358	0.000638	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000357	0.000638	CcSEcCtD
Meloxicam—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000355	0.000634	CcSEcCtD
Meloxicam—Renal failure—Doxorubicin—ovarian cancer	0.000354	0.000632	CcSEcCtD
Meloxicam—Haemoglobin—Epirubicin—ovarian cancer	0.000351	0.000627	CcSEcCtD
Meloxicam—Stomatitis—Doxorubicin—ovarian cancer	0.000351	0.000627	CcSEcCtD
Meloxicam—Jaundice—Doxorubicin—ovarian cancer	0.000351	0.000627	CcSEcCtD
Meloxicam—Rhinitis—Epirubicin—ovarian cancer	0.00035	0.000625	CcSEcCtD
Meloxicam—Urinary tract infection—Doxorubicin—ovarian cancer	0.00035	0.000625	CcSEcCtD
Meloxicam—Conjunctivitis—Doxorubicin—ovarian cancer	0.00035	0.000625	CcSEcCtD
Meloxicam—Haemorrhage—Epirubicin—ovarian cancer	0.00035	0.000624	CcSEcCtD
Meloxicam—Hepatitis—Epirubicin—ovarian cancer	0.00035	0.000624	CcSEcCtD
Meloxicam—Pharyngitis—Epirubicin—ovarian cancer	0.000347	0.000619	CcSEcCtD
Meloxicam—Sweating—Doxorubicin—ovarian cancer	0.000345	0.000617	CcSEcCtD
Meloxicam—Urinary tract disorder—Epirubicin—ovarian cancer	0.000345	0.000616	CcSEcCtD
Meloxicam—Urticaria—Paclitaxel—ovarian cancer	0.000345	0.000616	CcSEcCtD
Meloxicam—Oedema peripheral—Epirubicin—ovarian cancer	0.000344	0.000615	CcSEcCtD
Meloxicam—Hypotension—Docetaxel—ovarian cancer	0.000344	0.000614	CcSEcCtD
Meloxicam—Haematuria—Doxorubicin—ovarian cancer	0.000344	0.000613	CcSEcCtD
Meloxicam—Connective tissue disorder—Epirubicin—ovarian cancer	0.000343	0.000613	CcSEcCtD
Meloxicam—Body temperature increased—Paclitaxel—ovarian cancer	0.000343	0.000613	CcSEcCtD
Meloxicam—Abdominal pain—Paclitaxel—ovarian cancer	0.000343	0.000613	CcSEcCtD
Meloxicam—Urethral disorder—Epirubicin—ovarian cancer	0.000343	0.000612	CcSEcCtD
Meloxicam—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000341	0.000608	CcSEcCtD
Meloxicam—Sinusitis—Doxorubicin—ovarian cancer	0.000338	0.000603	CcSEcCtD
Meloxicam—Visual impairment—Epirubicin—ovarian cancer	0.000337	0.000601	CcSEcCtD
Meloxicam—Agranulocytosis—Doxorubicin—ovarian cancer	0.000336	0.0006	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000335	0.000599	CcSEcCtD
Meloxicam—Insomnia—Docetaxel—ovarian cancer	0.000333	0.000594	CcSEcCtD
Meloxicam—Paraesthesia—Docetaxel—ovarian cancer	0.000331	0.00059	CcSEcCtD
Meloxicam—Erythema multiforme—Epirubicin—ovarian cancer	0.00033	0.00059	CcSEcCtD
Meloxicam—Dyspnoea—Docetaxel—ovarian cancer	0.000328	0.000586	CcSEcCtD
Meloxicam—Somnolence—Docetaxel—ovarian cancer	0.000327	0.000584	CcSEcCtD
Meloxicam—Eye disorder—Epirubicin—ovarian cancer	0.000327	0.000583	CcSEcCtD
Meloxicam—Tinnitus—Epirubicin—ovarian cancer	0.000326	0.000582	CcSEcCtD
Meloxicam—Haemoglobin—Doxorubicin—ovarian cancer	0.000325	0.00058	CcSEcCtD
Meloxicam—Cardiac disorder—Epirubicin—ovarian cancer	0.000324	0.000579	CcSEcCtD
Meloxicam—Flushing—Epirubicin—ovarian cancer	0.000324	0.000579	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—ovarian cancer	0.000324	0.000579	CcSEcCtD
Meloxicam—Dyspepsia—Docetaxel—ovarian cancer	0.000324	0.000578	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—ovarian cancer	0.000323	0.000577	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—ovarian cancer	0.000323	0.000577	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—ovarian cancer	0.000321	0.000573	CcSEcCtD
Meloxicam—Decreased appetite—Docetaxel—ovarian cancer	0.00032	0.000571	CcSEcCtD
Meloxicam—Hypersensitivity—Paclitaxel—ovarian cancer	0.00032	0.000571	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000319	0.00057	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—ovarian cancer	0.000319	0.000569	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000318	0.000567	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000318	0.000567	CcSEcCtD
Meloxicam—Fatigue—Docetaxel—ovarian cancer	0.000317	0.000567	CcSEcCtD
Meloxicam—Angiopathy—Epirubicin—ovarian cancer	0.000317	0.000566	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—ovarian cancer	0.000317	0.000566	CcSEcCtD
Meloxicam—Immune system disorder—Epirubicin—ovarian cancer	0.000316	0.000564	CcSEcCtD
Meloxicam—Mediastinal disorder—Epirubicin—ovarian cancer	0.000315	0.000562	CcSEcCtD
Meloxicam—Constipation—Docetaxel—ovarian cancer	0.000315	0.000562	CcSEcCtD
Meloxicam—Pain—Docetaxel—ovarian cancer	0.000315	0.000562	CcSEcCtD
Meloxicam—Arrhythmia—Epirubicin—ovarian cancer	0.000312	0.000557	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—ovarian cancer	0.000312	0.000556	CcSEcCtD
Meloxicam—Asthenia—Paclitaxel—ovarian cancer	0.000312	0.000556	CcSEcCtD
Meloxicam—Alopecia—Epirubicin—ovarian cancer	0.000309	0.000551	CcSEcCtD
Meloxicam—Pruritus—Paclitaxel—ovarian cancer	0.000307	0.000549	CcSEcCtD
Meloxicam—Mental disorder—Epirubicin—ovarian cancer	0.000306	0.000547	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—ovarian cancer	0.000306	0.000546	CcSEcCtD
Meloxicam—Erythema—Epirubicin—ovarian cancer	0.000304	0.000543	CcSEcCtD
Meloxicam—Malnutrition—Epirubicin—ovarian cancer	0.000304	0.000543	CcSEcCtD
Meloxicam—Feeling abnormal—Docetaxel—ovarian cancer	0.000303	0.000542	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—ovarian cancer	0.000302	0.00054	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—ovarian cancer	0.000302	0.000538	CcSEcCtD
Meloxicam—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000301	0.000537	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—ovarian cancer	0.0003	0.000536	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—ovarian cancer	0.0003	0.000536	CcSEcCtD
Meloxicam—Flatulence—Epirubicin—ovarian cancer	0.0003	0.000535	CcSEcCtD
Meloxicam—Tension—Epirubicin—ovarian cancer	0.000299	0.000533	CcSEcCtD
Meloxicam—Dysgeusia—Epirubicin—ovarian cancer	0.000298	0.000532	CcSEcCtD
Meloxicam—Diarrhoea—Paclitaxel—ovarian cancer	0.000297	0.00053	CcSEcCtD
Meloxicam—Nervousness—Epirubicin—ovarian cancer	0.000296	0.000528	CcSEcCtD
Meloxicam—Back pain—Epirubicin—ovarian cancer	0.000294	0.000525	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—ovarian cancer	0.000293	0.000524	CcSEcCtD
Meloxicam—Muscle spasms—Epirubicin—ovarian cancer	0.000293	0.000522	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—ovarian cancer	0.000292	0.000521	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000291	0.00052	CcSEcCtD
Meloxicam—Abdominal pain—Docetaxel—ovarian cancer	0.000291	0.00052	CcSEcCtD
Meloxicam—Body temperature increased—Docetaxel—ovarian cancer	0.000291	0.00052	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—ovarian cancer	0.000289	0.000516	CcSEcCtD
Meloxicam—Dizziness—Paclitaxel—ovarian cancer	0.000287	0.000513	CcSEcCtD
Meloxicam—Vision blurred—Epirubicin—ovarian cancer	0.000287	0.000512	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—ovarian cancer	0.000286	0.00051	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—ovarian cancer	0.000283	0.000506	CcSEcCtD
Meloxicam—Ill-defined disorder—Epirubicin—ovarian cancer	0.000282	0.000504	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—ovarian cancer	0.000282	0.000503	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—ovarian cancer	0.000282	0.000503	CcSEcCtD
Meloxicam—Anaemia—Epirubicin—ovarian cancer	0.000281	0.000502	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—ovarian cancer	0.000277	0.000495	CcSEcCtD
Meloxicam—Tension—Doxorubicin—ovarian cancer	0.000276	0.000493	CcSEcCtD
Meloxicam—Vomiting—Paclitaxel—ovarian cancer	0.000276	0.000493	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—ovarian cancer	0.000276	0.000492	CcSEcCtD
Meloxicam—Malaise—Epirubicin—ovarian cancer	0.000274	0.00049	CcSEcCtD
Meloxicam—Rash—Paclitaxel—ovarian cancer	0.000274	0.000489	CcSEcCtD
Meloxicam—Dermatitis—Paclitaxel—ovarian cancer	0.000274	0.000488	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—ovarian cancer	0.000273	0.000488	CcSEcCtD
Meloxicam—Vertigo—Epirubicin—ovarian cancer	0.000273	0.000488	CcSEcCtD
Meloxicam—Syncope—Epirubicin—ovarian cancer	0.000273	0.000487	CcSEcCtD
Meloxicam—Leukopenia—Epirubicin—ovarian cancer	0.000272	0.000486	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—ovarian cancer	0.000272	0.000486	CcSEcCtD
Meloxicam—Headache—Paclitaxel—ovarian cancer	0.000272	0.000486	CcSEcCtD
Meloxicam—Hypersensitivity—Docetaxel—ovarian cancer	0.000271	0.000484	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—ovarian cancer	0.000271	0.000483	CcSEcCtD
Meloxicam—Palpitations—Epirubicin—ovarian cancer	0.000269	0.00048	CcSEcCtD
Meloxicam—Loss of consciousness—Epirubicin—ovarian cancer	0.000267	0.000477	CcSEcCtD
Meloxicam—Cough—Epirubicin—ovarian cancer	0.000266	0.000474	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—ovarian cancer	0.000265	0.000474	CcSEcCtD
Meloxicam—Asthenia—Docetaxel—ovarian cancer	0.000264	0.000472	CcSEcCtD
Meloxicam—Convulsion—Epirubicin—ovarian cancer	0.000264	0.000471	CcSEcCtD
Meloxicam—Hypertension—Epirubicin—ovarian cancer	0.000263	0.000469	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000261	0.000466	CcSEcCtD
Meloxicam—Pruritus—Docetaxel—ovarian cancer	0.00026	0.000465	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—ovarian cancer	0.00026	0.000464	CcSEcCtD
Meloxicam—Myalgia—Epirubicin—ovarian cancer	0.000259	0.000462	CcSEcCtD
Meloxicam—Arthralgia—Epirubicin—ovarian cancer	0.000259	0.000462	CcSEcCtD
Meloxicam—Anxiety—Epirubicin—ovarian cancer	0.000258	0.000461	CcSEcCtD
Meloxicam—Nausea—Paclitaxel—ovarian cancer	0.000258	0.000461	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000257	0.000459	CcSEcCtD
Meloxicam—Discomfort—Epirubicin—ovarian cancer	0.000256	0.000457	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—ovarian cancer	0.000254	0.000453	CcSEcCtD
Meloxicam—Dry mouth—Epirubicin—ovarian cancer	0.000253	0.000452	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—ovarian cancer	0.000253	0.000452	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—ovarian cancer	0.000252	0.000451	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—ovarian cancer	0.000252	0.00045	CcSEcCtD
Meloxicam—Diarrhoea—Docetaxel—ovarian cancer	0.000252	0.00045	CcSEcCtD
Meloxicam—Confusional state—Epirubicin—ovarian cancer	0.00025	0.000447	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—ovarian cancer	0.000249	0.000444	CcSEcCtD
Meloxicam—Oedema—Epirubicin—ovarian cancer	0.000248	0.000443	CcSEcCtD
Meloxicam—Anaphylactic shock—Epirubicin—ovarian cancer	0.000248	0.000443	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—ovarian cancer	0.000247	0.000442	CcSEcCtD
Meloxicam—Infection—Epirubicin—ovarian cancer	0.000247	0.00044	CcSEcCtD
Meloxicam—Cough—Doxorubicin—ovarian cancer	0.000246	0.000439	CcSEcCtD
Meloxicam—Shock—Epirubicin—ovarian cancer	0.000244	0.000436	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—ovarian cancer	0.000244	0.000435	CcSEcCtD
Meloxicam—Nervous system disorder—Epirubicin—ovarian cancer	0.000244	0.000435	CcSEcCtD
Meloxicam—Dizziness—Docetaxel—ovarian cancer	0.000243	0.000435	CcSEcCtD
Meloxicam—Thrombocytopenia—Epirubicin—ovarian cancer	0.000243	0.000434	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—ovarian cancer	0.000243	0.000434	CcSEcCtD
Meloxicam—Tachycardia—Epirubicin—ovarian cancer	0.000242	0.000433	CcSEcCtD
Meloxicam—Skin disorder—Epirubicin—ovarian cancer	0.000241	0.000431	CcSEcCtD
Meloxicam—Hyperhidrosis—Epirubicin—ovarian cancer	0.00024	0.000429	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—ovarian cancer	0.00024	0.000428	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—ovarian cancer	0.00024	0.000428	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—ovarian cancer	0.000239	0.000426	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000238	0.000425	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—ovarian cancer	0.000237	0.000423	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—ovarian cancer	0.000234	0.000418	CcSEcCtD
Meloxicam—Vomiting—Docetaxel—ovarian cancer	0.000234	0.000418	CcSEcCtD
Meloxicam—Rash—Docetaxel—ovarian cancer	0.000232	0.000414	CcSEcCtD
Meloxicam—Hypotension—Epirubicin—ovarian cancer	0.000232	0.000414	CcSEcCtD
Meloxicam—Dermatitis—Docetaxel—ovarian cancer	0.000232	0.000414	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—ovarian cancer	0.000232	0.000414	CcSEcCtD
Meloxicam—Headache—Docetaxel—ovarian cancer	0.000231	0.000412	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—ovarian cancer	0.00023	0.00041	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00023	0.00041	CcSEcCtD
Meloxicam—Infection—Doxorubicin—ovarian cancer	0.000228	0.000407	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000226	0.000404	CcSEcCtD
Meloxicam—Shock—Doxorubicin—ovarian cancer	0.000226	0.000404	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—ovarian cancer	0.000225	0.000402	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000225	0.000402	CcSEcCtD
Meloxicam—Insomnia—Epirubicin—ovarian cancer	0.000225	0.000401	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—ovarian cancer	0.000224	0.0004	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—ovarian cancer	0.000223	0.000398	CcSEcCtD
Meloxicam—Paraesthesia—Epirubicin—ovarian cancer	0.000223	0.000398	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000222	0.000396	CcSEcCtD
Meloxicam—Dyspnoea—Epirubicin—ovarian cancer	0.000221	0.000395	CcSEcCtD
Meloxicam—Somnolence—Epirubicin—ovarian cancer	0.000221	0.000394	CcSEcCtD
Meloxicam—Nausea—Docetaxel—ovarian cancer	0.000219	0.00039	CcSEcCtD
Meloxicam—Dyspepsia—Epirubicin—ovarian cancer	0.000219	0.00039	CcSEcCtD
Meloxicam—Decreased appetite—Epirubicin—ovarian cancer	0.000216	0.000385	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—ovarian cancer	0.000215	0.000383	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000214	0.000383	CcSEcCtD
Meloxicam—Fatigue—Epirubicin—ovarian cancer	0.000214	0.000382	CcSEcCtD
Meloxicam—Pain—Epirubicin—ovarian cancer	0.000212	0.000379	CcSEcCtD
Meloxicam—Constipation—Epirubicin—ovarian cancer	0.000212	0.000379	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000209	0.000374	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—ovarian cancer	0.000208	0.000371	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—ovarian cancer	0.000206	0.000368	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—ovarian cancer	0.000205	0.000366	CcSEcCtD
Meloxicam—Feeling abnormal—Epirubicin—ovarian cancer	0.000205	0.000365	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—ovarian cancer	0.000204	0.000365	CcSEcCtD
Meloxicam—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000203	0.000362	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—ovarian cancer	0.000202	0.000361	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—ovarian cancer	0.0002	0.000357	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000198	0.000354	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—ovarian cancer	0.000198	0.000354	CcSEcCtD
Meloxicam—Urticaria—Epirubicin—ovarian cancer	0.000197	0.000352	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—ovarian cancer	0.000196	0.000351	CcSEcCtD
Meloxicam—Pain—Doxorubicin—ovarian cancer	0.000196	0.000351	CcSEcCtD
Meloxicam—Body temperature increased—Epirubicin—ovarian cancer	0.000196	0.00035	CcSEcCtD
Meloxicam—Abdominal pain—Epirubicin—ovarian cancer	0.000196	0.00035	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000189	0.000338	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000188	0.000335	CcSEcCtD
Meloxicam—Hypersensitivity—Epirubicin—ovarian cancer	0.000183	0.000327	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—ovarian cancer	0.000183	0.000326	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—ovarian cancer	0.000182	0.000324	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—ovarian cancer	0.000182	0.000324	CcSEcCtD
Meloxicam—Asthenia—Epirubicin—ovarian cancer	0.000178	0.000318	CcSEcCtD
Meloxicam—Pruritus—Epirubicin—ovarian cancer	0.000176	0.000314	CcSEcCtD
Meloxicam—Diarrhoea—Epirubicin—ovarian cancer	0.00017	0.000303	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—ovarian cancer	0.000169	0.000302	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—ovarian cancer	0.000165	0.000294	CcSEcCtD
Meloxicam—Dizziness—Epirubicin—ovarian cancer	0.000164	0.000293	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—ovarian cancer	0.000163	0.00029	CcSEcCtD
Meloxicam—Vomiting—Epirubicin—ovarian cancer	0.000158	0.000282	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—ovarian cancer	0.000157	0.000281	CcSEcCtD
Meloxicam—Rash—Epirubicin—ovarian cancer	0.000157	0.000279	CcSEcCtD
Meloxicam—Dermatitis—Epirubicin—ovarian cancer	0.000156	0.000279	CcSEcCtD
Meloxicam—Headache—Epirubicin—ovarian cancer	0.000156	0.000278	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—ovarian cancer	0.000152	0.000271	CcSEcCtD
Meloxicam—Nausea—Epirubicin—ovarian cancer	0.000148	0.000263	CcSEcCtD
Meloxicam—Vomiting—Doxorubicin—ovarian cancer	0.000146	0.000261	CcSEcCtD
Meloxicam—Rash—Doxorubicin—ovarian cancer	0.000145	0.000259	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—ovarian cancer	0.000145	0.000258	CcSEcCtD
Meloxicam—Headache—Doxorubicin—ovarian cancer	0.000144	0.000257	CcSEcCtD
Meloxicam—Nausea—Doxorubicin—ovarian cancer	0.000136	0.000244	CcSEcCtD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	8.64e-05	0.00165	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—NRAS—ovarian cancer	8.56e-05	0.00163	CbGpPWpGaD
Meloxicam—PGD—Metabolism—TYMS—ovarian cancer	8.55e-05	0.00163	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2—ovarian cancer	8.41e-05	0.0016	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NME2—ovarian cancer	8.39e-05	0.0016	CbGpPWpGaD
Meloxicam—PGD—Disease—CAV1—ovarian cancer	8.23e-05	0.00157	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	8.13e-05	0.00155	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	7.98e-05	0.00152	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	7.95e-05	0.00151	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	7.94e-05	0.00151	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6ST—ovarian cancer	7.8e-05	0.00149	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	7.79e-05	0.00148	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	7.77e-05	0.00148	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BCL9—ovarian cancer	7.6e-05	0.00145	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	7.58e-05	0.00144	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	7.51e-05	0.00143	CbGpPWpGaD
Meloxicam—PGD—Disease—APC—ovarian cancer	7.49e-05	0.00143	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.4e-05	0.00141	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	7.37e-05	0.0014	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	7.36e-05	0.0014	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.31e-05	0.00139	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	7.28e-05	0.00139	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	7.15e-05	0.00136	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.12e-05	0.00136	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.03e-05	0.00134	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CAV1—ovarian cancer	6.89e-05	0.00131	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NME2—ovarian cancer	6.83e-05	0.0013	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYTB—ovarian cancer	6.81e-05	0.0013	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CAV1—ovarian cancer	6.77e-05	0.00129	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	6.76e-05	0.00129	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.66e-05	0.00127	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CD—ovarian cancer	6.59e-05	0.00126	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	6.44e-05	0.00123	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CG—ovarian cancer	6.28e-05	0.0012	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	6.27e-05	0.00119	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	6.25e-05	0.00119	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CG—ovarian cancer	6.16e-05	0.00117	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	6.08e-05	0.00116	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.01e-05	0.00115	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPP1CC—ovarian cancer	5.95e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—BRIP1—ovarian cancer	5.95e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	5.95e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	5.95e-05	0.00113	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	5.93e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	5.83e-05	0.00111	CbGpPWpGaD
Meloxicam—PGD—Disease—ERBB2—ovarian cancer	5.82e-05	0.00111	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.8e-05	0.00111	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.79e-05	0.0011	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	5.78e-05	0.0011	CbGpPWpGaD
Meloxicam—PGD—Disease—MTOR—ovarian cancer	5.74e-05	0.00109	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CB—ovarian cancer	5.74e-05	0.00109	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PPP1CC—ovarian cancer	5.64e-05	0.00108	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	5.58e-05	0.00106	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NME2—ovarian cancer	5.56e-05	0.00106	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CD—ovarian cancer	5.52e-05	0.00105	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CD—ovarian cancer	5.42e-05	0.00103	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYTB—ovarian cancer	5.41e-05	0.00103	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	5.4e-05	0.00103	CbGpPWpGaD
Meloxicam—PGD—Disease—CDKN1B—ovarian cancer	5.39e-05	0.00103	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	5.3e-05	0.00101	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.29e-05	0.00101	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	5.15e-05	0.000982	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	5.1e-05	0.000973	CbGpPWpGaD
Meloxicam—PGD—Disease—CTNNB1—ovarian cancer	5.09e-05	0.00097	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	4.99e-05	0.000951	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	4.98e-05	0.000948	CbGpPWpGaD
Meloxicam—PGD—Disease—PTEN—ovarian cancer	4.96e-05	0.000945	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CB—ovarian cancer	4.81e-05	0.000916	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—BRIP1—ovarian cancer	4.73e-05	0.000901	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPP1CC—ovarian cancer	4.73e-05	0.000901	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.72e-05	0.0009	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CB—ovarian cancer	4.72e-05	0.0009	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.71e-05	0.000898	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	4.57e-05	0.000871	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	4.56e-05	0.000869	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	4.49e-05	0.000856	CbGpPWpGaD
Meloxicam—PGD—Disease—STAT3—ovarian cancer	4.44e-05	0.000845	CbGpPWpGaD
Meloxicam—PGD—Disease—NRAS—ovarian cancer	4.43e-05	0.000843	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYTB—ovarian cancer	4.4e-05	0.000838	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.34e-05	0.000827	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—ovarian cancer	4.34e-05	0.000826	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.3e-05	0.000819	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HDAC6—ovarian cancer	4.28e-05	0.000815	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	4.25e-05	0.00081	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK3—ovarian cancer	4.24e-05	0.000808	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTEN—ovarian cancer	4.16e-05	0.000792	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	4.13e-05	0.000788	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—ovarian cancer	4.12e-05	0.000786	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.05e-05	0.000771	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.04e-05	0.000771	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK1—ovarian cancer	4.03e-05	0.000769	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—ovarian cancer	4.03e-05	0.000768	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—YAP1—ovarian cancer	3.99e-05	0.000761	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.95e-05	0.000753	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BRIP1—ovarian cancer	3.85e-05	0.000733	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPP1CC—ovarian cancer	3.85e-05	0.000733	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.84e-05	0.000732	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.82e-05	0.000728	CbGpPWpGaD
Meloxicam—PGD—Disease—KRAS—ovarian cancer	3.81e-05	0.000726	CbGpPWpGaD
Meloxicam—PTGS2—Disease—XIAP—ovarian cancer	3.71e-05	0.000707	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—ovarian cancer	3.69e-05	0.000702	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NME2—ovarian cancer	3.67e-05	0.000698	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NRAS—ovarian cancer	3.64e-05	0.000694	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SMARCA4—ovarian cancer	3.61e-05	0.000689	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYTB—ovarian cancer	3.58e-05	0.000682	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EREG—ovarian cancer	3.53e-05	0.000672	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.51e-05	0.000669	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.5e-05	0.000667	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—ovarian cancer	3.5e-05	0.000667	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK3—ovarian cancer	3.49e-05	0.000664	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.47e-05	0.000662	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.44e-05	0.000656	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.4e-05	0.000647	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK1—ovarian cancer	3.32e-05	0.000632	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—FASN—ovarian cancer	3.26e-05	0.00062	CbGpPWpGaD
Meloxicam—PGD—Disease—HRAS—ovarian cancer	3.24e-05	0.000617	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC5A5—ovarian cancer	3.2e-05	0.00061	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—YAP1—ovarian cancer	3.17e-05	0.000604	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.14e-05	0.000598	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—KRAS—ovarian cancer	3.13e-05	0.000597	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BRIP1—ovarian cancer	3.13e-05	0.000596	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPP1CC—ovarian cancer	3.13e-05	0.000596	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—ovarian cancer	3.1e-05	0.000591	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC2A1—ovarian cancer	3.09e-05	0.000589	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FASN—ovarian cancer	3.09e-05	0.000588	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PARP1—ovarian cancer	3.07e-05	0.000586	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.03e-05	0.000577	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1B1—ovarian cancer	2.97e-05	0.000565	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC2A1—ovarian cancer	2.93e-05	0.000559	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—ovarian cancer	2.93e-05	0.000559	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—ovarian cancer	2.88e-05	0.000548	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.87e-05	0.000546	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—ovarian cancer	2.86e-05	0.000545	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.8e-05	0.000534	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—ovarian cancer	2.78e-05	0.000531	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.76e-05	0.000526	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HRAS—ovarian cancer	2.66e-05	0.000507	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPP2R1A—ovarian cancer	2.63e-05	0.000501	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.62e-05	0.000499	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—FASN—ovarian cancer	2.58e-05	0.000492	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—YAP1—ovarian cancer	2.58e-05	0.000492	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.55e-05	0.000486	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC5A5—ovarian cancer	2.54e-05	0.000484	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PPP2R1A—ovarian cancer	2.49e-05	0.000475	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC2A1—ovarian cancer	2.46e-05	0.000468	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCB1—ovarian cancer	2.44e-05	0.000465	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.4e-05	0.000458	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TYMS—ovarian cancer	2.4e-05	0.000457	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—ovarian cancer	2.39e-05	0.000456	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYTB—ovarian cancer	2.36e-05	0.00045	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1B1—ovarian cancer	2.35e-05	0.000449	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—ovarian cancer	2.35e-05	0.000448	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.28e-05	0.000435	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.24e-05	0.000428	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—FASN—ovarian cancer	2.1e-05	0.000401	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—YAP1—ovarian cancer	2.1e-05	0.0004	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPP2R1A—ovarian cancer	2.09e-05	0.000398	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.08e-05	0.000396	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.08e-05	0.000396	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC5A5—ovarian cancer	2.07e-05	0.000394	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.06e-05	0.000393	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.06e-05	0.000393	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC2A1—ovarian cancer	2e-05	0.000381	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TERT—ovarian cancer	1.98e-05	0.000377	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.96e-05	0.000373	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCB1—ovarian cancer	1.94e-05	0.000369	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAV1—ovarian cancer	1.93e-05	0.000368	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.92e-05	0.000365	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMS—ovarian cancer	1.9e-05	0.000363	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.85e-05	0.000352	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CAV1—ovarian cancer	1.83e-05	0.000349	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.83e-05	0.000348	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.76e-05	0.000335	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6ST—ovarian cancer	1.74e-05	0.000331	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FASN—ovarian cancer	1.71e-05	0.000326	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.7e-05	0.000324	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.69e-05	0.000322	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.68e-05	0.000321	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—ovarian cancer	1.67e-05	0.000318	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.63e-05	0.00031	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.59e-05	0.000303	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.58e-05	0.000301	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.56e-05	0.000297	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMS—ovarian cancer	1.55e-05	0.000295	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.55e-05	0.000295	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAV1—ovarian cancer	1.53e-05	0.000292	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CD—ovarian cancer	1.47e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.47e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CG—ovarian cancer	1.4e-05	0.000266	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—YAP1—ovarian cancer	1.38e-05	0.000264	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.38e-05	0.000263	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.38e-05	0.000262	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CB—ovarian cancer	1.35e-05	0.000257	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB2—ovarian cancer	1.3e-05	0.000247	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.28e-05	0.000245	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTOR—ovarian cancer	1.28e-05	0.000244	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CB—ovarian cancer	1.28e-05	0.000244	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMS—ovarian cancer	1.26e-05	0.00024	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAV1—ovarian cancer	1.25e-05	0.000238	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CD—ovarian cancer	1.23e-05	0.000234	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1B—ovarian cancer	1.2e-05	0.000229	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.19e-05	0.000227	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTEN—ovarian cancer	1.17e-05	0.000222	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.14e-05	0.000217	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CTNNB1—ovarian cancer	1.13e-05	0.000216	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FASN—ovarian cancer	1.13e-05	0.000215	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.11e-05	0.000212	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PTEN—ovarian cancer	1.1e-05	0.00021	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.07e-05	0.000204	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CB—ovarian cancer	1.07e-05	0.000204	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.03e-05	0.000196	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAV1—ovarian cancer	1.02e-05	0.000194	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1e-05	0.00019	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—ovarian cancer	9.88e-06	0.000188	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NRAS—ovarian cancer	9.86e-06	0.000188	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.71e-06	0.000185	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK3—ovarian cancer	9.44e-06	0.00018	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CG—ovarian cancer	9.25e-06	0.000176	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTEN—ovarian cancer	9.25e-06	0.000176	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—ovarian cancer	9.18e-06	0.000175	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	9.12e-06	0.000174	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK1—ovarian cancer	8.98e-06	0.000171	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—ovarian cancer	8.98e-06	0.000171	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CB—ovarian cancer	8.71e-06	0.000166	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KRAS—ovarian cancer	8.48e-06	0.000162	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.47e-06	0.000161	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMS—ovarian cancer	8.32e-06	0.000158	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—ovarian cancer	8.22e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CD—ovarian cancer	8.14e-06	0.000155	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—ovarian cancer	7.79e-06	0.000149	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTEN—ovarian cancer	7.53e-06	0.000143	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HRAS—ovarian cancer	7.21e-06	0.000137	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CB—ovarian cancer	7.09e-06	0.000135	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—ovarian cancer	6.9e-06	0.000131	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—ovarian cancer	6.72e-06	0.000128	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAV1—ovarian cancer	6.7e-06	0.000128	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—ovarian cancer	6.53e-06	0.000124	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—ovarian cancer	6.37e-06	0.000121	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTEN—ovarian cancer	6.13e-06	0.000117	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.1e-06	0.000116	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.37e-06	0.000102	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—ovarian cancer	5.33e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—ovarian cancer	5.31e-06	0.000101	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.68e-06	8.91e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—ovarian cancer	4.34e-06	8.27e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.32e-06	8.24e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTEN—ovarian cancer	4.04e-06	7.7e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—ovarian cancer	3.53e-06	6.73e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.85e-06	5.43e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—ovarian cancer	2.33e-06	4.44e-05	CbGpPWpGaD
